Frost & Sullivan Recognizes ValveXchange's Pioneering Heart Valve Technology for Unique Long-term Management and Future Replacement Advantages
... In other bioprosthetic valves particularly bovine
pericardial valves, the
pericardial tissue leaflets are permanently attached to the ... is designed to be on par with the Edwards bovine
pericardial valve, the most commonly used tissue valve. ...
Childhood Cancer Survivors Prone to Early Heart Trouble
... disease; more than six times likelier to have
pericardial disease (the pericardium is the sac that ... about fourfold, roughly doubled the risk of
pericardial and valvular disease, and almost tripled the odds ... of congestive heart failure, heart attack and
pericardial disease, almost tripled the risk of valvular ...
CorMatrix Cardiovascular to Present on its ECM Technology(TM) at the Annual Advanced Cardiac Techniques in Surgery (ACTS) Symposium in New York, N.Y.
... and with more than 10,000 implants we are creating a paradigm shift in
pericardial closure and cardiac tissue repair."
About CorMatrix(R) ECM ... European approval with a CE Mark for its ECM Technology as an implant for
pericardial closure, and clearance in the U.S. for use in cardiac tissue repair.
...
CorMatrix Cardiovascular Announces First European Implants of CorMatrix(R) ECM Technology(TM)
... applications. Since the launch of the CorMatrix(R) ECM (TM) for
pericardial Closure, the technology has been used at more than 220 hospitals across ... European approval with a CE Mark for its ECM Technology as an implant for
pericardial closure, and clearance in the U.S. for use in cardiac tissue repair.
...
Edwards Lifesciences Receives CE Mark for Edwards SAPIEN Transcatheter Heart Valve
... without requiring open-heart surgery. It is
the first transcatheter bovine
pericardial valve incorporating
technological advancements and design elements that ... stent technology that leverages Edwards' proprietary
bovine
pericardial tissue and 30 years of design and manufacturing
expertise. With the ...
ATS Medical Announces Participation in the Joint Meeting of the Society for Heart Valve Disease and Heart Valve Society of America
... Bioprosthesis which is designed to replace the patient's diseased valve. The ATS 3f Aortic Bioprosthesis is a revolutionary next generation stentless
pericardial aortic tissue valve that is unlike any other valve with its tubular design that restores continuity between the annulus and the sinotubular junction. ...
Cell Therapeutics Completes Pixantrone NDA Submission and Requests Priority Review
... agents (8.8% vs. 4.5%). Events considered cardiac disorders included cardiac arrest, congestive heart failure, myocardial infarction, cyanosis,
pericardial effusion, and tachycardia.
About Pixantrone
Pixantrone (BBR 2778), is a novel major groove binder with an aza-anthracenedione molecular ...
ATS Medical Announces Participation in the International Society for Minimally Invasive Cardiothoracic Surgery Meeting
... Bioprosthesis which is designed to replace the patient's diseased valve. The ATS 3f Aortic Bioprosthesis is a revolutionary next generation stentless
pericardial aortic tissue valve that is unlike any other valve with its tubular design that restores continuity between the annulus and the sinotubular junction. ...
ATS Medical Announces Australian Regulatory Approval for ATS 3f Aortic Bioprosthesis
... )
Based on the precept that 'Form Follows Function', the ATS 3f Aortic
Bioprosthesis is a revolutionary next generation stentless
pericardial aortic
tissue valve that is unlike any other valve. The primary benefit of the ATS
3f Aortic Bioprosthesis is its tubular design that restores ...
Schering-Plough Completes Enrollment of Boceprevir Registration Studies in Treatment-Naive and Treatment-Experienced HCV Patients
... psychosis, aggressive reaction, relapse of drug addiction/overdose; nerve palsy (facial, oculomotor); cardiomyopathy, myocardial infarction, angina,
pericardial effusion, retinal ischemia, retinal artery or vein thrombosis, blindness, decreased visual acuity, optic neuritis, transient ischemic attack, ...
Pericardial in Medical Technology
CorMatrix(R) Announces Intramyocardial Injection of Emulsified ECM Technology(TM) Demonstrates Enhanced Angiogenesis and Improved Cardiac Function in a Preclinical Model
... is U.S. Food and Drug
Administration (FDA) cleared and in use for
pericardial closure. The
Company is researching a variety of cardiovascular ... approval to market the CorMatrix ECM Technology(TM) as an
implant for
pericardial closure.
About CorMatrix Cardiovascular, Inc.
CorMatrix ...
St. Francis Surgeon Uses Tissue Regeneration Technology to Rebuild Patients' Heart Structures
... cardiovascular applications. The company currently has U.S. clearance and European approval with a CE Mark for its ECM Technology as an implant for
pericardial closure, and clearance in the U.S. for use in cardiac tissue repair. For more information, visit www.cormatrix.com .
...
Responses After Completion of Therapy Increase Pixantrone Complete Remission (CR)/Unconfirmed Complete Remission (CRu) Rate to 24% and Overall Response Rate (ORR) to 40% Compared to 7% and 14% for Comparator Agents in Phase III EXTEND Trial in 3rd Line Th
... agents (8.8% vs. 4.5%). Events considered cardiac disorders included cardiac arrest, congestive heart failure, myocardial infarction, cyanosis,
pericardial effusion, and tachycardia.
In April 2009, CTI began a rolling submission of a New Drug Application (the "NDA") with the FDA for pixantrone to ...
Pixantrone Produces High Rates of Complete and Partial Remissions Even Among Aggressive NHL Patients With Extensive Prior Doxorubicin Treatment or Prior Rituximab Treatment
... agents (8.8% vs. 4.5%). Events considered cardiac disorders included cardiac arrest, congestive heart failure, myocardial infarction, cyanosis,
pericardial effusion, and tachycardia.
The ASCO poster is available at http://www.celltherapeutics.com/investor_updates .
In April 2009, CTI began ...
Schering-Plough Highlights Hepatitis C Clinical Data Presentations at the European Association for the Study of the Liver (EASL) Annual Meeting
... psychosis, aggressive reaction, relapse of drug addiction/overdose; nerve palsy (facial, oculomotor); cardiomyopathy, myocardial infarction, angina,
pericardial effusion, retinal ischemia, retinal artery or vein thrombosis, blindness, decreased visual acuity, optic neuritis, transient ischemic attack, ...
Final Results of Boceprevir Phase II HCV SPRINT-1 Study Showed Significantly Higher SVR Rates Compared to Standard of Care in Treatment-Naive Genotype 1 Hepatitis C Patients
... psychosis, aggressive reaction, relapse of drug addiction/overdose; nerve palsy (facial, oculomotor); cardiomyopathy, myocardial infarction, angina,
pericardial effusion, retinal ischemia, retinal artery or vein thrombosis, blindness, decreased visual acuity, optic neuritis, transient ischemic attack, ...
FDA Approves an Expanded Indication for Peginterferon-Based Combination Therapy for Patients With Chronic Hepatitis C
... psychosis, aggressive reaction, relapse of drug addiction/overdose; nerve palsy (facial, oculomotor); cardiomyopathy, myocardial infarction, angina,
pericardial effusion, retinal ischemia, retinal artery or vein thrombosis, blindness, decreased visual acuity, optic neuritis, transient ischemic attack, ...
Preliminary Analyses from Phase 2 Genzyme Study Highlight Efficacy and Safety of Clofarabine in Older Adult AML Patients
... through the kidneys. Concomitant use of
medications known to induce hepatic toxicity should be avoided. Cardiac
disorders, including tachycardia,
pericardial effusion, and left
ventricular systolic dysfunction, have been noted in up to 35% of pediatric
patients treated with Clolar. However, the presence of ...
Alfacell Corporation Announces Preliminary Results From ONCONASE(R) Phase IIIb Clinical Trial
... form, accounting for about 80 percent of all cases. Another 15
to 20 percent of the cases are peritoneal mesothelioma (in the abdominal
cavity).
pericardial mesothelioma, in the tissue around the heart, is
extremely rare.
There are over 15,000 new cases of malignant mesothelioma diagnosed
each year ...
IDM Pharma Announces Updated Data From Mifamurtide (L-MTP-PE) Compassionate Access Program
... flu-like symptoms with the first dose.
This was prevented with ibuprofen and acetaminophen after subsequent doses.
One patient developed pleural and
pericardial effusion that was possibly
L-MTP-PE and/or GM-CSF related and the patient was removed from the study.
In March, the Company announced that it had ...
Pericardial in Medical Products
SJM Pericardial Patch
Description:... The SJM
pericardial Patch with EnCap technology is used for cardiac and great vessel reconstruction/repair and for
pericardial closure. It is glutaraldehyde-treated bovine ... and the complications that may follow. The SJM
pericardial Patch has EnCap technology applied, which has ...
Company:St. Jude Medical, Inc.
Freezor Xtra
Description:... to surgically treat cardiac arrhythmias in the
pericardial space by minimally surgical techniques or during ... sternum and advanced through an opening in the
pericardial sac to reach the target epicardial location.
CryoAblation is well suited in the
pericardial space as this area has no blood flow. Thanks to ...
Company:CryoCath Technologies, Inc.
OctoBase Retractor System
Description:... retractor allows countless Octopus stabilizer mounting options. The unique rail slot design allows for multiple blade configurations as well as
pericardial suture ....
Company:Medtronic Inc.
ACROBAT SUV Vacuum Off-Pump System
Description:... to spread the sternum, providing access and direct visualization to the thoracic cavity. The AccessRail Platform also allows for the organization of
pericardial sutures. The stabilizer isolates and provides local immobilization of the target vessel on the beating ....
Company:Guidant Corporation
Glucose, Pericardial
Description: ARUP Laboratories is a national reference laboratory and a worldwide leader in innovative laboratory research and development. ARUP offers an extensive test menu of highly complex and unique medical tests in clinical and anatomic pathology. Owned by the University of Utah, ARUP Laboratories' ...
Company:ARUP Laboratories
Pericardial in Medical Dictionary
Cardiac tamponade
... pericarditis , where inflammation of the
pericardial sac results in fibrosis and thickening of the ... tamponade . In this situation, the inflamed
pericardial sac fills with fluid and restricts the heart ... Here the outpouring of fluid within the
pericardial sac is, so to speak, smashing into the heart ....
Effusion
... language development in children. Causes of
pericardial effusion include: Infection Inflammatory ... known as empyema . This condition is known as
pericardial effusion and it can cause a number of serious ... chest wall), which can cause shortness of breath
pericardial effusion s (fluid around the heart ), which can ...
Pericardiocentesis
... Pericardiocentesis Alternative Names:
pericardial tap; Percutaneous pericardiocentesis What ... ) to remove and drain the excess fluid from the
pericardial cavity . Percarditis: Chest Radiograph- Pre ... pericardiocentesis with chemical analysis and
pericardial fluid culture ... If excessive fluid has ...
Sac
... with pericarditis also have some fluid in the
pericardial sac . This condition is known as
pericardial effusion and it can cause a number of serious ... pericarditis , where inflammation of the
pericardial sac results in fibrosis and thickening of the ...
Pericardium
... Next Image > ... HEMO PERICARDIUM - A collection of blood in the
pericardial sac surrounding the heart . [ Med Help International ] [ Search ] [ Ask ... pathology . Constrictive pericarditis , where inflammation of the
pericardial sac results in fibrosis and thickening of the pericardium with ...
Pleura
... l effusion , including assessment and treatment options. Malignant
pericardial effusion , including assessment and treatment options. Superior vena ... between the lung and chest wall), which can cause shortness of breath
pericardial effusion s (fluid around the heart ), which can cause shortness of ...
Pleural effusion
... pleural effusion , including assessment and treatment options. Malignant
pericardial effusion , including assessment and treatment options. Superior vena ... between the lung and chest wall), which can cause shortness of breath
pericardial effusion s (fluid around the heart ), which can cause shortness of ...
Blood culture
... CBC , may show increased WBC count C-reactive protein erythrocyte sedimentation rate ( ESR ) pericardiocentesis with chemical analysis and
pericardial fluid culture ... Anaerobic Bacteria , Blood Culture For Aspartate Aminotransferase ( AST ) Aspartate Transaminase ( AST ) AST Biopsy -- ...
Breath sounds
... the lungs , decreased breath sounds , or other signs of fluid in the space around the lungs ( pleural effusion ). If fluid has accumulated in the
pericardial sac , it may show on: ... Check for normal breathing , taking no more than 10 seconds: Look for chest motion, listen for breath sounds , and ...
Cardiomyopathy
... for the treatment of diabetic nephropathy and cardiomyopathy . Abnormal results may indicate heart valve disease , cardiomyopathy ,
pericardial effusion , or other cardiac abnormalities. Additional conditions under which the test may be performed include the following: ... Lashus, ...
More>>
Pericardial in Biological Technology
Frost & Sullivan Presents CorMatrix Cardiovascular Inc. with 2008 Healthcare Innovation Award for the Treatment of Cardiovascular Disease
... and marketing
of its ECM Technology(TM) for
pericardial closure and cardiac tissue
repair.
"Frost & ... Since the launch of
CorMatrix's ECM for
pericardial Closure, the technology has been used at
more ... to market its ECM
Technology as an implant for
pericardial closure, clearance in the U.S. for
cardiac tissue ...
CorMatrix Announces Pre-Clinical Data Suggesting Next Generation ECM Technology(TM) Can Improve Cardiac Function
... Since the launch of
CorMatrix's ECM for
pericardial Closure, the technology has been used at
more ... from the clinical community for
our products for
pericardial closure and for cardiac tissue repair," ... to market its ECM
Technology as an implant for
pericardial closure, FDA clearance in the U.S.
for cardiac ...
CorMatrix(R) Announces FDA 510(k) for Novel Biomaterial Implant for Intracardiac Repair
... the CorMatrix ECM(TM) for
pericardial Closure
ATLANTA, May 8 /PRNewswire/ -- ... anatomy complete with normal
pericardial space," said Douglas
Boyd, M.D., Chief of ... results make it an excellent option
for
pericardial closure and now for other cardiac tissue ...
FDA Approves New SPRYCEL(R) (Dasatinib) Product Labeling for Patients with Chronic-Phase CML
... edema (2%, 1%),
congestive heart failure/cardiac dysfunction (0%, 4%),
pericardial effusion
(1%, 2%), pulmonary edema (0%, 2%), pulmonary hypertension (0%, ... edema (2%, 4%), congestive heart
failure/cardiac dysfunction (2%, 0%),
pericardial effusion (1%, 0%),
pulmonary edema (3%, 0%), pulmonary hypertension (1%, ...
Pixantrone Significantly Increases Complete Remissions, Overall Response Rates, Frequency of Durable Remissions and Progression Free Survival in Patients with Relapsed and Refractory Aggressive Non-Hodgkin's Lymphoma
... agents (8.8% vs. 4.5%). Events considered cardiac disorders included cardiac arrest, congestive heart failure, myocardial infarction, cyanosis,
pericardial effusion, and tachycardia.
The ASCO poster is available at http://www.celltherapeutics.com/investor_updates .
In April 2009, CTI ...
ATS Medical Announces Participation in the Annual Meeting of the American Association for Thoracic Surgeons
... Aortic Bioprosthesis designed to replace the patient's diseased valve. The ATS 3f Aortic Bioprosthesis is a revolutionary next generation stentless
pericardial aortic tissue valve that is unlike any other valve with its tubular design that restores continuity between the annulus and the sinotubular junction. ...
ATS Medical Provides Update on US Commercialization of Its ATS 3f Aortic Bioprosthesis
... the future."
Based on the precept that 'Form Follows Function', the ATS 3f Aortic
Bioprosthesis is a revolutionary next generation stentless
pericardial aortic
tissue valve that is unlike any other valve. The tubular design of the ATS 3f
Aortic Bioprosthesis maintains the continuity of the annulus and ...
CorMatrix Cardiovascular to Present Data on Its Next Generation ECM Technology(TM) at Annual Transcatheter Cardiovascular Therapeutics (TCT) Conference in Washington, D.C.
... applications. The company currently has
U.S. clearance and European approval with a CE Mark to market its ECM
Technology as an implant for
pericardial closure, clearance in the U.S. for
cardiac tissue repair, and is conducting preclinical studies on a number of
cardiovascular applications including ...
The Modern DeBakey VAD™ To Be Introduced For the First Time in the U.S. : HeartAssist 5™ Pediatric VAD Features Industry Exclusive Direct Blood Flow Measurement System
... and measures just 2.8 x 1.2 inches. Because of its small size, it is one of the few pediatric VADs that can be implanted above the diaphragm in the
pericardial space surrounding the heart, which reduces the risk of complications.
DeBakey will be honored multiple times during this week. On the evening ...
Edwards Lifesciences Celebrates One Million Heart Valve Patients and More at AATS 2008
... -- Regulatory and reimbursement approval received this week from the Japanese Ministry of Health for the Carpentier-Edwards PERIMOUNT Magna
pericardial aortic heart valve. As the first and only device of its kind, this valve combines more than 20 years of clinical experience and innovation ...
Pericardial in Biological Dictionary
Pericardial cavity
... The
pericardial cavity is a potential space between the parietal ... that is found in this space is known as the
pericardial fluid. ... cavity (such as in a
pericardial effusion) can result in ...